160 related articles for article (PubMed ID: 8630885)
1. Aspirin and reduced risk of esophageal carcinoma.
Funkhouser EM; Sharp GB
Cancer; 1995 Oct; 76(7):1116-9. PubMed ID: 8630885
[TBL] [Abstract][Full Text] [Related]
2. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer.
Farrow DC; Vaughan TL; Hansten PD; Stanford JL; Risch HA; Gammon MD; Chow WH; Dubrow R; Ahsan H; Mayne ST; Schoenberg JB; West AB; Rotterdam H; Fraumeni JF; Blot WJ
Cancer Epidemiol Biomarkers Prev; 1998 Feb; 7(2):97-102. PubMed ID: 9488582
[TBL] [Abstract][Full Text] [Related]
3. Regular aspirin use and esophageal cancer risk.
Jayaprakash V; Menezes RJ; Javle MM; McCann SE; Baker JA; Reid ME; Natarajan N; Moysich KB
Int J Cancer; 2006 Jul; 119(1):202-7. PubMed ID: 16450404
[TBL] [Abstract][Full Text] [Related]
4. Nonsteroidal anti-inflammatory drugs and esophageal inflammation - Barrett's esophagus - adenocarcinoma sequence: a meta-analysis.
Wang F; Lv ZS; Fu YK
Dis Esophagus; 2011 Jul; 24(5):318-24. PubMed ID: 21166737
[TBL] [Abstract][Full Text] [Related]
5. Protective association of aspirin/NSAIDs and esophageal cancer: a systematic review and meta-analysis.
Corley DA; Kerlikowske K; Verma R; Buffler P
Gastroenterology; 2003 Jan; 124(1):47-56. PubMed ID: 12512029
[TBL] [Abstract][Full Text] [Related]
6. Aspirin, nonsteroidal anti-inflammatory drugs, and the risks of cancers of the esophagus.
Sadeghi S; Bain CJ; Pandeya N; Webb PM; Green AC; Whiteman DC;
Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1169-78. PubMed ID: 18483339
[TBL] [Abstract][Full Text] [Related]
7. Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County.
Duan L; Wu AH; Sullivan-Halley J; Bernstein L
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):126-34. PubMed ID: 18187391
[TBL] [Abstract][Full Text] [Related]
8. Statin use is associated with a reduction in the incidence of esophageal adenocarcinoma: a case control study.
Beales IL; Vardi I; Dearman L; Broughton T
Dis Esophagus; 2013; 26(8):838-46. PubMed ID: 22989236
[TBL] [Abstract][Full Text] [Related]
9. Meta-analysis: non-steroidal anti-inflammatory drug use and the risk of esophageal squamous cell carcinoma.
Sun L; Yu S
Dis Esophagus; 2011 Nov; 24(8):544-9. PubMed ID: 21539676
[TBL] [Abstract][Full Text] [Related]
10. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence.
Anderson LA; Johnston BT; Watson RG; Murphy SJ; Ferguson HR; Comber H; McGuigan J; Reynolds JV; Murray LJ
Cancer Res; 2006 May; 66(9):4975-82. PubMed ID: 16651456
[TBL] [Abstract][Full Text] [Related]
11. Gastro-oesophageal reflux symptoms and the risks of oesophageal cancer: are the effects modified by smoking, NSAIDs or acid suppressants?
Pandeya N; Webb PM; Sadeghi S; Green AC; Whiteman DC;
Gut; 2010 Jan; 59(1):31-8. PubMed ID: 19875392
[TBL] [Abstract][Full Text] [Related]
12. Aspirin and esophageal squamous cell carcinoma: bedside to bench.
Li P; Cheng R; Zhang S
Chin Med J (Engl); 2014; 127(7):1365-9. PubMed ID: 24709195
[TBL] [Abstract][Full Text] [Related]
13. Regular adult aspirin use decreases the risk of non-small cell lung cancer among women.
Van Dyke AL; Cote ML; Prysak G; Claeys GB; Wenzlaff AS; Schwartz AG
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):148-57. PubMed ID: 18187393
[TBL] [Abstract][Full Text] [Related]
14. Aspirin and cancer risk: an update to 2001.
Bosetti C; Gallus S; La Vecchia C
Eur J Cancer Prev; 2002 Dec; 11(6):535-42. PubMed ID: 12457105
[TBL] [Abstract][Full Text] [Related]
15. NSAIDS and esophageal cancer.
Scherübl H; Sutter AP; Zeitz M
Gastroenterology; 2003 Dec; 125(6):1914-5; author reply 1915. PubMed ID: 14727630
[No Abstract] [Full Text] [Related]
16. Low dose aspirin prevents duodenoesophageal reflux induced mucosal changes in wistar rat esophagus by MAP kinase mediated pathways.
Selvan B; Ramachandran A; Korula A; Amirtharaj GJ; Kettimuthu K; Nair S; Nair A; Samuel P; Mathew G
Int J Surg; 2012; 10(2):73-9. PubMed ID: 22197650
[TBL] [Abstract][Full Text] [Related]
17. Aspirin and other non-steroidal anti-inflammatory drug prescriptions and survival after the diagnosis of head and neck and oesophageal cancer.
Macfarlane TV; Murchie P; Watson MC
Cancer Epidemiol; 2015 Dec; 39(6):1015-22. PubMed ID: 26590503
[TBL] [Abstract][Full Text] [Related]
18. Determination of risk for Barrett's esophagus and esophageal adenocarcinoma.
Thrift AP
Curr Opin Gastroenterol; 2016 Jul; 32(4):319-24. PubMed ID: 27276368
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and nonsteroidal anti-inflammatory drugs can prevent cutaneous squamous cell carcinoma: a systematic review and meta-analysis.
Muranushi C; Olsen CM; Pandeya N; Green AC
J Invest Dermatol; 2015 Apr; 135(4):975-983. PubMed ID: 25521453
[TBL] [Abstract][Full Text] [Related]
20. A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence.
Jacobs EJ; Rodriguez C; Mondul AM; Connell CJ; Henley SJ; Calle EE; Thun MJ
J Natl Cancer Inst; 2005 Jul; 97(13):975-80. PubMed ID: 15998950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
